David T. Plante, MD, PhD, explains that separating mood-related sleepiness from primary hypersomnia relies on the course of illness and sleep testing.
Commentary|Webinars|November 9, 2026
Medical Aid in Dying: Law, Ethics, and Choice
Advertisement
As medical aid in dying becomes part of the end-of-life care landscape in more states, difficult questions remain about safeguards, patient autonomy, and clinician responsibility. The American Journal of Managed Care® and Pharmacy Times® are partnering to present a multidisciplinary panel spanning medical ethics, psychiatry, law, and patient advocacy. Register for the free webinar to hear expert insights that can help managed care leaders make informed organizational decisions that keep patients’ best interests at the center.
Advertisement
Related to this article
Six studies found liver transplant disparities by insurance, region, ethnicity, and sex, plus links between unmet social needs and frailty in cirrhosis.
The glucagon/GLP-1 dual agonist is noninferior to placebo for major adverse cardiovascular events and lowers blood pressure and waist size.
Health systems are using pharmacist-run titration clinics, auto-consult triggers, and discharge follow-up to close gaps in HFpEF and HFmrEF care.
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Phase 3 Viti-Up trials show Rinvoq (upadacitinib) JAK inhibitor boosts facial and body repigmentation in nonsegmental vitiligo, with familiar safety.
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
A population-based study of 1102 Canadian children found infants with bone and soft tissue tumors had poorer survival, driven largely by treatment deaths.
Advertisement
Advertisement
Trending on AJMC
1
Hepatitis B Functional Cure Persists Off Treatment After Bepirovirsen
2
COPD’s Old Narrative Is Outdated, GOLD Leaders Say in 2027 Update
3
Survodutide Meets CV Safety End Point in SYNCHRONIZE-CVOT
4
Data Show Upadacitinib Repigments Skin in Nonsegmental Vitiligo
5